Advertisement
Advertisement
APUS
Apimeds Pharmaceuticals US, Inc.
2.71
USDSponsored
-0.02
-0.92%
Nov 06, 15:59 UTC -5
Closed
Pre-Market
2.70
0.00
-0.04%
Apimeds Pharmaceuticals US, Inc. (APUS)
Apimeds Pharmaceuticals US, Inc. Financial Snapshot
| Market Cap | 4.08M |
| Beta | 0.13 |
| Earnings Per Share (EPS) | -36.57 |
| Price-to-Book (P/B) Ratio | 0.04 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 13.53% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -59.01% |
| Current Ratio | 0.51% |
| Free Cash Flow | -7.74M |
